Purchase the ATMP report at www.evernowpublishing.com

Subscribe to MedNous and get ahead in the business of medical innovation. Subscribe now.

The latest MedNous journal. Subscribe to download.

Kymab succeeds in patent challenge

Country: United Kingdom

Kymab Ltd has successfully challenged a European patent issued to its competitor, Regeneron Pharmaceuticals Inc, for transgenic mouse technology that is a foundation for developing therapeutic antibodies. The patent was said to lack an inventive step as required by European patent law.

Read more

GSK’s China entity ordered to pay fine

Country: United Kingdom

A court in Hunan Province, China has found GlaxoSmithKline’s subsidiary, GSK China Investment Co Ltd (GSKCI), guilty of bribing non-government personnel and ordered it to pay a fine of £297 million, the UK company announced on 19 September.

Read more

Evotec to sue Andromeda

Country: Germany

Read more

Bayer to float its materials science business

Country: Germany

Read more

OSE Pharma plans IPO on Euronext Paris

Country: France

Read more

Big Pharma partnerships accelerate

Country: United Kingdom

Read more

MGB Biopharma raises funds for antibiotic

Country: United Kingdom

Read more

MorphoSys gets funding for GPCR projects

Country: Germany

Read more

TB trial results published in the NEJM

Country: United States

Read more

Nicox buys more ophthalmic assets

Country: France

Read more

Long-term data said positive for allergy therapy

Country: Switzerland

Read more

Merck KGaA stops tecemotide in lung cancer

Country: Germany

Read more

Looking for more?

Visit our news section for more articles.

News
Our full Mednous news archive
Appointments
Latest industry appointments
Events
A list of upcoming industry events

About Mednous

MedNous is a print publication and a website for everyone involved in medical research in Europe.

Read more

Free Article

How Britain champions medical innovation

UKasBiocentreSept2014.pdf

Highlights of the September 2014 MedNous issue

The September 2014 MedNous features:

Latest Mednous cover
  • Financial Strategy
    How Versant Ventures
    builds to buy
  • Research Strategy
    New targets for
    malaria vaccines
  • Public Policy
    Britain champions
    medical innovation
  • Commentary
    Getting traction against
    antimicrobial resistance
    By Dawn Firmin
  • Commentary
    Expanding medicine access
    through formulation
    By Thomas Reese Saylor

The latest MedNous journal. Subscribe to download.

Recent Appointments